Prosecution Insights
Last updated: October 04, 2026

Kaohsiung Medical University

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems

8 pending office actions • 5 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Kaohsiung Medical University maintains a portfolio with 7 pending office actions, all situated within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 7 distinct examiners and 5 distinct art units. This distribution suggests a diverse range of research and development projects that fall under different specialized review groups within the patent office. The university must manage multiple simultaneous legal tracks across these divisions.

MAMADOU FAYE is identified as the busiest examiner for the university, currently handling 1 pending office action. Because each of the 7 distinct examiners is only handling 1 matter, the workload is evenly spread across the examining corps. The involvement of 5 distinct art units indicates that while the technology area is consistent, the specific applications cover various sub-disciplines within biotechnology. This breadth of 7 pending office actions requires a coordinated approach to prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

8
Total Pending OAs
6
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

6
Hard (75%)
2
Medium (25%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (38%)
§103 only2 (25%)
Multi-statute (no §101)3 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
38% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
25% of docket
3
Business / Other
38% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FAYE, MAMADOU 1 78.8% +6.5%
BARR, MARY EVANGELINE 1 35.8% +32.6%
WOLFF, ARIELLE R 1 47.1% +34.7%
RAMACHANDRAN, UMAMAHESWARI 1 54.6% +53.8%
HRANEK, KAREN AMANDA 1 34.5% +39.9%
JONES, CHRISTINE MICHELLE 1 0.0% +0.0%
KALLAL, ROBERT JAMES 1 60.0% +32.4%
WRIGHT, SARAH C 1 41.6% +46.0%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17855736 METHOD FOR ESTABLISHING ROBUST PREDICTION MODEL, PREDICTION SYSTEM, AND PROGNOSTIC SYSTEM FOR ALZHEIMER'S DISEASE KALLAL, ROBERT JAMES 15d
18901161 ARTIFICIAL INTELLIGENCE MODEL DEVICE OF ESTIMATING SURVIVAL RATES OF CRITICALLY ILL PATIENT BARR, MARY EVANGELINE —
18746502 Endotracheal tube position anomaly alerting device WOLFF, ARIELLE R —
18715132 Tellurium-containing compounds and the use of treating bacterial infections thereof RAMACHANDRAN, UMAMAHESWARI —
18578721 CLINICAL THERAPEUTIC DRUG PREDICTION AND RECOMMENDATION SYSTEM AND METHOD FOR EVALUATING EFFICACY OF SECOND-GENERATION HORMONE DRUG IN TREATMENT OF PROSTATE CANCER HRANEK, KAREN AMANDA —
18506147 Method for detection of single nucleotide variant JONES, CHRISTINE MICHELLE —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17697935 METHOD FOR PREPARING ZONAL LAYERED CHONDROCYTE SHEETS AND TREATING METHOD THEREOF WRIGHT, SARAH C 146d overdue
17855736 METHOD FOR ESTABLISHING ROBUST PREDICTION MODEL, PREDICTION SYSTEM, AND PROGNOSTIC SYSTEM FOR ALZHEIMER'S DISEASE KALLAL, ROBERT JAMES 15d
18901161 ARTIFICIAL INTELLIGENCE MODEL DEVICE OF ESTIMATING SURVIVAL RATES OF CRITICALLY ILL PATIENT BARR, MARY EVANGELINE —
18746502 Endotracheal tube position anomaly alerting device WOLFF, ARIELLE R —
18715132 Tellurium-containing compounds and the use of treating bacterial infections thereof RAMACHANDRAN, UMAMAHESWARI —
18578721 CLINICAL THERAPEUTIC DRUG PREDICTION AND RECOMMENDATION SYSTEM AND METHOD FOR EVALUATING EFFICACY OF SECOND-GENERATION HORMONE DRUG IN TREATMENT OF PROSTATE CANCER HRANEK, KAREN AMANDA —

Top Art Units

Art UnitApps
3682 1
3684 1
1682 1
1685 1
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19010213 TEST PHANTOM FOR EVALUATING ELECTROMAGNETIC RADIATION IMAGES FAYE, MAMADOU — §103 Non-Final OA — Pending Jan 06, 2025
18901161 ARTIFICIAL INTELLIGENCE MODEL DEVICE OF ESTIMATING SURVIVAL RATES OF CRITICALLY ILL PATIENT BARR, MARY EVANGELINE 3682 §103§112 Final Rejection — Pending Sep 30, 2024
18746502 Endotracheal tube position anomaly alerting device WOLFF, ARIELLE R — §101§102§103§112 Non-Final OA — Pending Jun 18, 2024
18715132 Tellurium-containing compounds and the use of treating bacterial infections thereof RAMACHANDRAN, UMAMAHESWARI — §102§103§112 Non-Final OA — Pending May 31, 2024
18578721 CLINICAL THERAPEUTIC DRUG PREDICTION AND RECOMMENDATION SYSTEM AND METHOD FOR EVALUATING EFFICACY OF SECOND-GENERATION HORMONE DRUG IN TREATMENT OF PROSTATE CANCER HRANEK, KAREN AMANDA 3684 §101§112 Non-Final OA — Pending Jan 12, 2024
18506147 Method for detection of single nucleotide variant JONES, CHRISTINE MICHELLE 1682 §103§112 Final Rejection — Pending Nov 10, 2023
17855736 METHOD FOR ESTABLISHING ROBUST PREDICTION MODEL, PREDICTION SYSTEM, AND PROGNOSTIC SYSTEM FOR ALZHEIMER'S DISEASE KALLAL, ROBERT JAMES 1685 §101§102§103 Non-Final OA 15d Pending Jun 30, 2022
17697935 METHOD FOR PREPARING ZONAL LAYERED CHONDROCYTE SHEETS AND TREATING METHOD THEREOF WRIGHT, SARAH C 1619 §103 Non-Final OA 146d overdue Pending Mar 18, 2022

Managing Kaohsiung Medical University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month